Impact Beyond Returns

Impact Beyond Returns

What We Do

Blackstone is a leading global investment business investing capital on behalf of pension funds, large institutions and individuals. Our mission is to create long-term value for our investors through the careful stewardship of their capital. We invest across the alternative asset classes in private equity, real estate, credit and hedge funds as well as in infrastructure, life sciences, insurance, and growth equity. Our efforts and capital grow hundreds of companies and support local economies.
Core+ Debt Global Opportunistic Real Estate
Life Sciences Infrastructure Growth Equity Tactical Opportunities Secondaries Private Equity
Commingled GP Stakes Seeding Hedge Fund Solutions
Performing Insurance Stressed/ Distressed Credit & Insurance

Highlights

Market Views

FT Op-Ed: Blackstone President Jon Gray on How Private Capital Will Help Support the Economic Recovery from COVID-19

April 30, 2020
Jon Gray discusses the essential role private capital is playing in supporting businesses, increasing economic resiliency and accelerating growth in critical sectors of the economy.
Read more
Portfolio Insights

Blackstone Portfolio Companies' COVID-19 Relief Efforts

May 05, 2020
Learn how Blackstone portfolio companies are helping their communities during the COVID-19 pandemic
Read more
PRESS RELEASE

NIBC and Blackstone agree on an amended recommended all-cash public offer for all NIBC shares

July 13, 2020
NIBC and the Offeror have reached conditional agreement on an amended recommended all-cash public offer for all issued and outstanding shares in the capital of NIBC.
Learn More
Portfolio Insights

Blackstone and Alnylam Announce Collaboration to Advance New Class of Medicines to Patients

April 13, 2020
The $2 billion investment will support the development of promising medicines with the potential to transform patients’ lives.
Read more
PRESS RELEASE

Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund

July 09, 2020
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the inaugural Blackstone fund in Life Sciences. BXLS V was oversubscribed and closed at its hard cap of $4.6 billion of total capital commitments — the largest life sciences private fund raised to date.
Learn More
Firm News

Steve Schwarzman and Jon Gray’s statement on racial injustices

June 01, 2020
We thought it important to share a message that Steve Schwarzman and Jon Gray sent to all employees today.
Read more

Stay up-to-date